Nucleic Acid Therapeutics CDMO Market Size, Share & Trends Analysis Report By Type (Cell & Gene Therapies, RNA-based Therapies, mRNA Therapies, siRNA Therapies, Others), By Service (Process Development & Optimization Services, Manufacturing Services, Analytical & Quality Control Services, Others), By End Use (Pharmaceutical & Biotechnology Companies, Government & Academic Research Institutes) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Last Updated: August 24, 2026 | Author: Debashree Bora | Format:

Table Of Content

  1. Executive Summary

  2. Research Scope & Segmentation
    1. Research Objectives
    2. Limitations & Assumptions
    3. Market Scope & Segmentation
    4. Currency & Pricing Considered
  3. Market Opportunity Assessment
    1. Emerging Regions / Countries
    2. Emerging Companies
    3. Emerging Applications / End Use
  4. Market Trends
    1. Drivers
    2. Market Warning Factors
    3. Macro Economic Indicators
    4. Geopolitical Impact
    5. Technology Factors
  5. Market Assessment
    1. Porters Five Forces Analysis
    2. Value Chain Analysis
  6. Nucleic Acid Therapeutics CDMO Market Size Analysis
    1. Introduction
    2. Nucleic Acid Therapeutics CDMO Market Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
      1. Cell & Gene Therapies
      2. RNA-based Therapies
      3. mRNA Therapies
      4. siRNA Therapies
      5. Others
    3. Nucleic Acid Therapeutics CDMO Market Market Size & Forecast By Service 2022-2034 (USD MILLION/ Units)
      1. Process Development & Optimization Services
      2. Manufacturing Services
      3. Analytical & Quality Control Services
      4. Others
    4. Nucleic Acid Therapeutics CDMO Market Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
      1. Pharmaceutical & Biotechnology Companies
      2. Government & Academic Research Institutes
  7. North America Nucleic Acid Therapeutics CDMO Market Size Analysis
    1. Introduction
    2. Nucleic Acid Therapeutics CDMO Market Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
      1. Cell & Gene Therapies
      2. RNA-based Therapies
      3. mRNA Therapies
      4. siRNA Therapies
      5. Others
    3. Nucleic Acid Therapeutics CDMO Market Market Size & Forecast By Service 2022-2034 (USD MILLION/ Units)
      1. Process Development & Optimization Services
      2. Manufacturing Services
      3. Analytical & Quality Control Services
      4. Others
    4. Nucleic Acid Therapeutics CDMO Market Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
      1. Pharmaceutical & Biotechnology Companies
      2. Government & Academic Research Institutes
    5. U.S.
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Cell & Gene Therapies
        2. RNA-based Therapies
        3. mRNA Therapies
        4. siRNA Therapies
        5. Others
      3. Market Size & Forecast By Service 2022-2034 (USD MILLION/ Units)
        1. Process Development & Optimization Services
        2. Manufacturing Services
        3. Analytical & Quality Control Services
        4. Others
      4. Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
        1. Pharmaceutical & Biotechnology Companies
        2. Government & Academic Research Institutes
    6. Canada
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Cell & Gene Therapies
        2. RNA-based Therapies
        3. mRNA Therapies
        4. siRNA Therapies
        5. Others
      3. Market Size & Forecast By Service 2022-2034 (USD MILLION/ Units)
        1. Process Development & Optimization Services
        2. Manufacturing Services
        3. Analytical & Quality Control Services
        4. Others
      4. Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
        1. Pharmaceutical & Biotechnology Companies
        2. Government & Academic Research Institutes
  8. Europe Nucleic Acid Therapeutics CDMO Market Size Analysis
    1. Introduction
    2. Nucleic Acid Therapeutics CDMO Market Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
      1. Cell & Gene Therapies
      2. RNA-based Therapies
      3. mRNA Therapies
      4. siRNA Therapies
      5. Others
    3. Nucleic Acid Therapeutics CDMO Market Market Size & Forecast By Service 2022-2034 (USD MILLION/ Units)
      1. Process Development & Optimization Services
      2. Manufacturing Services
      3. Analytical & Quality Control Services
      4. Others
    4. Nucleic Acid Therapeutics CDMO Market Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
      1. Pharmaceutical & Biotechnology Companies
      2. Government & Academic Research Institutes
    5. U.K.
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Cell & Gene Therapies
        2. RNA-based Therapies
        3. mRNA Therapies
        4. siRNA Therapies
        5. Others
      3. Market Size & Forecast By Service 2022-2034 (USD MILLION/ Units)
        1. Process Development & Optimization Services
        2. Manufacturing Services
        3. Analytical & Quality Control Services
        4. Others
      4. Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
        1. Pharmaceutical & Biotechnology Companies
        2. Government & Academic Research Institutes
    6. Germany
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Cell & Gene Therapies
        2. RNA-based Therapies
        3. mRNA Therapies
        4. siRNA Therapies
        5. Others
      3. Market Size & Forecast By Service 2022-2034 (USD MILLION/ Units)
        1. Process Development & Optimization Services
        2. Manufacturing Services
        3. Analytical & Quality Control Services
        4. Others
      4. Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
        1. Pharmaceutical & Biotechnology Companies
        2. Government & Academic Research Institutes
    7. France
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Cell & Gene Therapies
        2. RNA-based Therapies
        3. mRNA Therapies
        4. siRNA Therapies
        5. Others
      3. Market Size & Forecast By Service 2022-2034 (USD MILLION/ Units)
        1. Process Development & Optimization Services
        2. Manufacturing Services
        3. Analytical & Quality Control Services
        4. Others
      4. Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
        1. Pharmaceutical & Biotechnology Companies
        2. Government & Academic Research Institutes
    8. Spain
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Cell & Gene Therapies
        2. RNA-based Therapies
        3. mRNA Therapies
        4. siRNA Therapies
        5. Others
      3. Market Size & Forecast By Service 2022-2034 (USD MILLION/ Units)
        1. Process Development & Optimization Services
        2. Manufacturing Services
        3. Analytical & Quality Control Services
        4. Others
      4. Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
        1. Pharmaceutical & Biotechnology Companies
        2. Government & Academic Research Institutes
    9. Italy
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Cell & Gene Therapies
        2. RNA-based Therapies
        3. mRNA Therapies
        4. siRNA Therapies
        5. Others
      3. Market Size & Forecast By Service 2022-2034 (USD MILLION/ Units)
        1. Process Development & Optimization Services
        2. Manufacturing Services
        3. Analytical & Quality Control Services
        4. Others
      4. Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
        1. Pharmaceutical & Biotechnology Companies
        2. Government & Academic Research Institutes
    10. Russia
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Cell & Gene Therapies
        2. RNA-based Therapies
        3. mRNA Therapies
        4. siRNA Therapies
        5. Others
      3. Market Size & Forecast By Service 2022-2034 (USD MILLION/ Units)
        1. Process Development & Optimization Services
        2. Manufacturing Services
        3. Analytical & Quality Control Services
        4. Others
      4. Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
        1. Pharmaceutical & Biotechnology Companies
        2. Government & Academic Research Institutes
    11. Nordic
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Cell & Gene Therapies
        2. RNA-based Therapies
        3. mRNA Therapies
        4. siRNA Therapies
        5. Others
      3. Market Size & Forecast By Service 2022-2034 (USD MILLION/ Units)
        1. Process Development & Optimization Services
        2. Manufacturing Services
        3. Analytical & Quality Control Services
        4. Others
      4. Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
        1. Pharmaceutical & Biotechnology Companies
        2. Government & Academic Research Institutes
    12. Benelux
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Cell & Gene Therapies
        2. RNA-based Therapies
        3. mRNA Therapies
        4. siRNA Therapies
        5. Others
      3. Market Size & Forecast By Service 2022-2034 (USD MILLION/ Units)
        1. Process Development & Optimization Services
        2. Manufacturing Services
        3. Analytical & Quality Control Services
        4. Others
      4. Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
        1. Pharmaceutical & Biotechnology Companies
        2. Government & Academic Research Institutes
    13. Rest of Europe
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Cell & Gene Therapies
        2. RNA-based Therapies
        3. mRNA Therapies
        4. siRNA Therapies
        5. Others
      3. Market Size & Forecast By Service 2022-2034 (USD MILLION/ Units)
        1. Process Development & Optimization Services
        2. Manufacturing Services
        3. Analytical & Quality Control Services
        4. Others
      4. Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
        1. Pharmaceutical & Biotechnology Companies
        2. Government & Academic Research Institutes
  9. APAC Nucleic Acid Therapeutics CDMO Market Size Analysis
    1. Introduction
    2. Nucleic Acid Therapeutics CDMO Market Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
      1. Cell & Gene Therapies
      2. RNA-based Therapies
      3. mRNA Therapies
      4. siRNA Therapies
      5. Others
    3. Nucleic Acid Therapeutics CDMO Market Market Size & Forecast By Service 2022-2034 (USD MILLION/ Units)
      1. Process Development & Optimization Services
      2. Manufacturing Services
      3. Analytical & Quality Control Services
      4. Others
    4. Nucleic Acid Therapeutics CDMO Market Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
      1. Pharmaceutical & Biotechnology Companies
      2. Government & Academic Research Institutes
    5. China
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Cell & Gene Therapies
        2. RNA-based Therapies
        3. mRNA Therapies
        4. siRNA Therapies
        5. Others
      3. Market Size & Forecast By Service 2022-2034 (USD MILLION/ Units)
        1. Process Development & Optimization Services
        2. Manufacturing Services
        3. Analytical & Quality Control Services
        4. Others
      4. Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
        1. Pharmaceutical & Biotechnology Companies
        2. Government & Academic Research Institutes
    6. Korea
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Cell & Gene Therapies
        2. RNA-based Therapies
        3. mRNA Therapies
        4. siRNA Therapies
        5. Others
      3. Market Size & Forecast By Service 2022-2034 (USD MILLION/ Units)
        1. Process Development & Optimization Services
        2. Manufacturing Services
        3. Analytical & Quality Control Services
        4. Others
      4. Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
        1. Pharmaceutical & Biotechnology Companies
        2. Government & Academic Research Institutes
    7. Japan
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Cell & Gene Therapies
        2. RNA-based Therapies
        3. mRNA Therapies
        4. siRNA Therapies
        5. Others
      3. Market Size & Forecast By Service 2022-2034 (USD MILLION/ Units)
        1. Process Development & Optimization Services
        2. Manufacturing Services
        3. Analytical & Quality Control Services
        4. Others
      4. Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
        1. Pharmaceutical & Biotechnology Companies
        2. Government & Academic Research Institutes
    8. India
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Cell & Gene Therapies
        2. RNA-based Therapies
        3. mRNA Therapies
        4. siRNA Therapies
        5. Others
      3. Market Size & Forecast By Service 2022-2034 (USD MILLION/ Units)
        1. Process Development & Optimization Services
        2. Manufacturing Services
        3. Analytical & Quality Control Services
        4. Others
      4. Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
        1. Pharmaceutical & Biotechnology Companies
        2. Government & Academic Research Institutes
    9. Australia
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Cell & Gene Therapies
        2. RNA-based Therapies
        3. mRNA Therapies
        4. siRNA Therapies
        5. Others
      3. Market Size & Forecast By Service 2022-2034 (USD MILLION/ Units)
        1. Process Development & Optimization Services
        2. Manufacturing Services
        3. Analytical & Quality Control Services
        4. Others
      4. Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
        1. Pharmaceutical & Biotechnology Companies
        2. Government & Academic Research Institutes
    10. Taiwan
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Cell & Gene Therapies
        2. RNA-based Therapies
        3. mRNA Therapies
        4. siRNA Therapies
        5. Others
      3. Market Size & Forecast By Service 2022-2034 (USD MILLION/ Units)
        1. Process Development & Optimization Services
        2. Manufacturing Services
        3. Analytical & Quality Control Services
        4. Others
      4. Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
        1. Pharmaceutical & Biotechnology Companies
        2. Government & Academic Research Institutes
    11. South East Asia
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Cell & Gene Therapies
        2. RNA-based Therapies
        3. mRNA Therapies
        4. siRNA Therapies
        5. Others
      3. Market Size & Forecast By Service 2022-2034 (USD MILLION/ Units)
        1. Process Development & Optimization Services
        2. Manufacturing Services
        3. Analytical & Quality Control Services
        4. Others
      4. Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
        1. Pharmaceutical & Biotechnology Companies
        2. Government & Academic Research Institutes
    12. Rest of Asia-Pacific
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Cell & Gene Therapies
        2. RNA-based Therapies
        3. mRNA Therapies
        4. siRNA Therapies
        5. Others
      3. Market Size & Forecast By Service 2022-2034 (USD MILLION/ Units)
        1. Process Development & Optimization Services
        2. Manufacturing Services
        3. Analytical & Quality Control Services
        4. Others
      4. Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
        1. Pharmaceutical & Biotechnology Companies
        2. Government & Academic Research Institutes
  10. Middle East and Africa Nucleic Acid Therapeutics CDMO Market Size Analysis
    1. Introduction
    2. Nucleic Acid Therapeutics CDMO Market Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
      1. Cell & Gene Therapies
      2. RNA-based Therapies
      3. mRNA Therapies
      4. siRNA Therapies
      5. Others
    3. Nucleic Acid Therapeutics CDMO Market Market Size & Forecast By Service 2022-2034 (USD MILLION/ Units)
      1. Process Development & Optimization Services
      2. Manufacturing Services
      3. Analytical & Quality Control Services
      4. Others
    4. Nucleic Acid Therapeutics CDMO Market Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
      1. Pharmaceutical & Biotechnology Companies
      2. Government & Academic Research Institutes
    5. UAE
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Cell & Gene Therapies
        2. RNA-based Therapies
        3. mRNA Therapies
        4. siRNA Therapies
        5. Others
      3. Market Size & Forecast By Service 2022-2034 (USD MILLION/ Units)
        1. Process Development & Optimization Services
        2. Manufacturing Services
        3. Analytical & Quality Control Services
        4. Others
      4. Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
        1. Pharmaceutical & Biotechnology Companies
        2. Government & Academic Research Institutes
    6. Turkey
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Cell & Gene Therapies
        2. RNA-based Therapies
        3. mRNA Therapies
        4. siRNA Therapies
        5. Others
      3. Market Size & Forecast By Service 2022-2034 (USD MILLION/ Units)
        1. Process Development & Optimization Services
        2. Manufacturing Services
        3. Analytical & Quality Control Services
        4. Others
      4. Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
        1. Pharmaceutical & Biotechnology Companies
        2. Government & Academic Research Institutes
    7. Saudi Arabia
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Cell & Gene Therapies
        2. RNA-based Therapies
        3. mRNA Therapies
        4. siRNA Therapies
        5. Others
      3. Market Size & Forecast By Service 2022-2034 (USD MILLION/ Units)
        1. Process Development & Optimization Services
        2. Manufacturing Services
        3. Analytical & Quality Control Services
        4. Others
      4. Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
        1. Pharmaceutical & Biotechnology Companies
        2. Government & Academic Research Institutes
    8. South Africa
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Cell & Gene Therapies
        2. RNA-based Therapies
        3. mRNA Therapies
        4. siRNA Therapies
        5. Others
      3. Market Size & Forecast By Service 2022-2034 (USD MILLION/ Units)
        1. Process Development & Optimization Services
        2. Manufacturing Services
        3. Analytical & Quality Control Services
        4. Others
      4. Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
        1. Pharmaceutical & Biotechnology Companies
        2. Government & Academic Research Institutes
    9. Egypt
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Cell & Gene Therapies
        2. RNA-based Therapies
        3. mRNA Therapies
        4. siRNA Therapies
        5. Others
      3. Market Size & Forecast By Service 2022-2034 (USD MILLION/ Units)
        1. Process Development & Optimization Services
        2. Manufacturing Services
        3. Analytical & Quality Control Services
        4. Others
      4. Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
        1. Pharmaceutical & Biotechnology Companies
        2. Government & Academic Research Institutes
    10. Nigeria
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Cell & Gene Therapies
        2. RNA-based Therapies
        3. mRNA Therapies
        4. siRNA Therapies
        5. Others
      3. Market Size & Forecast By Service 2022-2034 (USD MILLION/ Units)
        1. Process Development & Optimization Services
        2. Manufacturing Services
        3. Analytical & Quality Control Services
        4. Others
      4. Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
        1. Pharmaceutical & Biotechnology Companies
        2. Government & Academic Research Institutes
    11. Rest of MEA
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Cell & Gene Therapies
        2. RNA-based Therapies
        3. mRNA Therapies
        4. siRNA Therapies
        5. Others
      3. Market Size & Forecast By Service 2022-2034 (USD MILLION/ Units)
        1. Process Development & Optimization Services
        2. Manufacturing Services
        3. Analytical & Quality Control Services
        4. Others
      4. Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
        1. Pharmaceutical & Biotechnology Companies
        2. Government & Academic Research Institutes
  11. LATAM Nucleic Acid Therapeutics CDMO Market Size Analysis
    1. Introduction
    2. Nucleic Acid Therapeutics CDMO Market Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
      1. Cell & Gene Therapies
      2. RNA-based Therapies
      3. mRNA Therapies
      4. siRNA Therapies
      5. Others
    3. Nucleic Acid Therapeutics CDMO Market Market Size & Forecast By Service 2022-2034 (USD MILLION/ Units)
      1. Process Development & Optimization Services
      2. Manufacturing Services
      3. Analytical & Quality Control Services
      4. Others
    4. Nucleic Acid Therapeutics CDMO Market Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
      1. Pharmaceutical & Biotechnology Companies
      2. Government & Academic Research Institutes
    5. Brazil
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Cell & Gene Therapies
        2. RNA-based Therapies
        3. mRNA Therapies
        4. siRNA Therapies
        5. Others
      3. Market Size & Forecast By Service 2022-2034 (USD MILLION/ Units)
        1. Process Development & Optimization Services
        2. Manufacturing Services
        3. Analytical & Quality Control Services
        4. Others
      4. Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
        1. Pharmaceutical & Biotechnology Companies
        2. Government & Academic Research Institutes
    6. Mexico
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Cell & Gene Therapies
        2. RNA-based Therapies
        3. mRNA Therapies
        4. siRNA Therapies
        5. Others
      3. Market Size & Forecast By Service 2022-2034 (USD MILLION/ Units)
        1. Process Development & Optimization Services
        2. Manufacturing Services
        3. Analytical & Quality Control Services
        4. Others
      4. Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
        1. Pharmaceutical & Biotechnology Companies
        2. Government & Academic Research Institutes
    7. Argentina
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Cell & Gene Therapies
        2. RNA-based Therapies
        3. mRNA Therapies
        4. siRNA Therapies
        5. Others
      3. Market Size & Forecast By Service 2022-2034 (USD MILLION/ Units)
        1. Process Development & Optimization Services
        2. Manufacturing Services
        3. Analytical & Quality Control Services
        4. Others
      4. Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
        1. Pharmaceutical & Biotechnology Companies
        2. Government & Academic Research Institutes
    8. Chile
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Cell & Gene Therapies
        2. RNA-based Therapies
        3. mRNA Therapies
        4. siRNA Therapies
        5. Others
      3. Market Size & Forecast By Service 2022-2034 (USD MILLION/ Units)
        1. Process Development & Optimization Services
        2. Manufacturing Services
        3. Analytical & Quality Control Services
        4. Others
      4. Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
        1. Pharmaceutical & Biotechnology Companies
        2. Government & Academic Research Institutes
    9. Colombia
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Cell & Gene Therapies
        2. RNA-based Therapies
        3. mRNA Therapies
        4. siRNA Therapies
        5. Others
      3. Market Size & Forecast By Service 2022-2034 (USD MILLION/ Units)
        1. Process Development & Optimization Services
        2. Manufacturing Services
        3. Analytical & Quality Control Services
        4. Others
      4. Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
        1. Pharmaceutical & Biotechnology Companies
        2. Government & Academic Research Institutes
    10. Rest of LATAM
      1. Introduction
      2. Market Size & Forecast By Type 2022-2034 (USD MILLION/ Units)
        1. Cell & Gene Therapies
        2. RNA-based Therapies
        3. mRNA Therapies
        4. siRNA Therapies
        5. Others
      3. Market Size & Forecast By Service 2022-2034 (USD MILLION/ Units)
        1. Process Development & Optimization Services
        2. Manufacturing Services
        3. Analytical & Quality Control Services
        4. Others
      4. Market Size & Forecast By End Use 2022-2034 (USD MILLION/ Units)
        1. Pharmaceutical & Biotechnology Companies
        2. Government & Academic Research Institutes
  12. Competitive Landscape
    1. Nucleic Acid Therapeutics CDMO Market Share By Players
    2. M&A Agreements & Collaboration Analysis
    3. Tier Structure Analysis
    4. Recent Developments
  13. Market Players Assessment
    1. Agilent Technologies, Inc.
      1. Overview
      2. Business Information
      3. Revenue
      4. ASP
      5. SWOT Analysis
      6. Recent Developments
    2. Thermo Fisher Scientific Inc.
    3. Danaher
    4. Lonza Group AG
    5. Catalent Inc.
    6. WuXi AppTec Co., Ltd.
    7. Bachem AG
    8. BioSpring GmbH
    9. TriLink BioTechnologies
    10. Eurofins Scientific
    11. Ajinomoto Bio-Pharma Services
    12. AGC Biologics, Inc.
    13. PolyPeptide Group AG
    14. Nitto Denko Avecia Inc.
    15. Kaneka Eurogentec S.A.
    16. LGC Group
    17. KNC Laboratories Co., Ltd.
    18. Merck KGaA
    19. Curia Global Inc.
    20. Asymchem Inc.
  14. Research Methodology
    1. Research Data
      1. Secondary Data
        1. Major Secondary Sources
        2. Key Data from Secondary Sources
      2. Primary Data
        1. Key Data from Primary Sources
        2. Breakdown of Primaries
      3. Secondary And Primary Research
        1. Key Industry Insights
    2. Market Size Estimation
      1. Bottom-Up Approach
      2. Top-Down Approach
      3. Market Projection
    3. Research Assumptions
      1. Assumptions
    4. Limitations
    5. Risk Assessment
  15. Appendix
    1. Discussion Guide
    2. Customization Options
    3. Related Reports

  16. Disclaimer

List of Tables

Table 1: Global Nucleic Acid Therapeutics CDMO Market Size and Forecast By Regions - 2022-2034 (USD Billion)

Table 2: Global Nucleic Acid Therapeutics CDMO Market Size and Forecast By Type - 2022-2034 (USD Billion)

Table 3: Global Nucleic Acid Therapeutics CDMO Market Size and Forecast By Service - 2022-2034 (USD Billion)

Table 4: Global Nucleic Acid Therapeutics CDMO Market Size and Forecast By End Use - 2022-2034 (USD Billion)

Table 5: North America Nucleic Acid Therapeutics CDMO Market Size and Forecast By Country - 2022-2034 (USD Billion)

Table 6: North America Nucleic Acid Therapeutics CDMO Market Size and Forecast By Type - 2022-2034 (USD Billion)

Table 7: North America Nucleic Acid Therapeutics CDMO Market Size and Forecast By Service - 2022-2034 (USD Billion)

Table 8: North America Nucleic Acid Therapeutics CDMO Market Size and Forecast By End Use - 2022-2034 (USD Billion)

Table 9: U.S. Nucleic Acid Therapeutics CDMO Market Size and Forecast By Type - 2022-2034 (USD Billion)

Table 10: U.S. Nucleic Acid Therapeutics CDMO Market Size and Forecast By Service - 2022-2034 (USD Billion)

Table 11: U.S. Nucleic Acid Therapeutics CDMO Market Size and Forecast By End Use - 2022-2034 (USD Billion)

Table 12: Canada Nucleic Acid Therapeutics CDMO Market Size and Forecast By Type - 2022-2034 (USD Billion)

Table 13: Canada Nucleic Acid Therapeutics CDMO Market Size and Forecast By Service - 2022-2034 (USD Billion)

Table 14: Canada Nucleic Acid Therapeutics CDMO Market Size and Forecast By End Use - 2022-2034 (USD Billion)

Table 15: Europe Nucleic Acid Therapeutics CDMO Market Size and Forecast By Country - 2022-2034 (USD Billion)

Table 16: Europe Nucleic Acid Therapeutics CDMO Market Size and Forecast By Type - 2022-2034 (USD Billion)

Table 17: Europe Nucleic Acid Therapeutics CDMO Market Size and Forecast By Service - 2022-2034 (USD Billion)

Table 18: Europe Nucleic Acid Therapeutics CDMO Market Size and Forecast By End Use - 2022-2034 (USD Billion)

Table 19: U.K. Nucleic Acid Therapeutics CDMO Market Size and Forecast By Type - 2022-2034 (USD Billion)

Table 20: U.K. Nucleic Acid Therapeutics CDMO Market Size and Forecast By Service - 2022-2034 (USD Billion)

Table 21: U.K. Nucleic Acid Therapeutics CDMO Market Size and Forecast By End Use - 2022-2034 (USD Billion)

Table 22: Germany Nucleic Acid Therapeutics CDMO Market Size and Forecast By Type - 2022-2034 (USD Billion)

Table 23: Germany Nucleic Acid Therapeutics CDMO Market Size and Forecast By Service - 2022-2034 (USD Billion)

Table 24: Germany Nucleic Acid Therapeutics CDMO Market Size and Forecast By End Use - 2022-2034 (USD Billion)

Table 25: France Nucleic Acid Therapeutics CDMO Market Size and Forecast By Type - 2022-2034 (USD Billion)

Table 26: France Nucleic Acid Therapeutics CDMO Market Size and Forecast By Service - 2022-2034 (USD Billion)

Table 27: France Nucleic Acid Therapeutics CDMO Market Size and Forecast By End Use - 2022-2034 (USD Billion)

Table 28: Spain Nucleic Acid Therapeutics CDMO Market Size and Forecast By Type - 2022-2034 (USD Billion)

Table 29: Spain Nucleic Acid Therapeutics CDMO Market Size and Forecast By Service - 2022-2034 (USD Billion)

Table 30: Spain Nucleic Acid Therapeutics CDMO Market Size and Forecast By End Use - 2022-2034 (USD Billion)

Table 31: Italy Nucleic Acid Therapeutics CDMO Market Size and Forecast By Type - 2022-2034 (USD Billion)

Table 32: Italy Nucleic Acid Therapeutics CDMO Market Size and Forecast By Service - 2022-2034 (USD Billion)

Table 33: Italy Nucleic Acid Therapeutics CDMO Market Size and Forecast By End Use - 2022-2034 (USD Billion)

Table 34: Russia Nucleic Acid Therapeutics CDMO Market Size and Forecast By Type - 2022-2034 (USD Billion)

Table 35: Russia Nucleic Acid Therapeutics CDMO Market Size and Forecast By Service - 2022-2034 (USD Billion)

Table 36: Russia Nucleic Acid Therapeutics CDMO Market Size and Forecast By End Use - 2022-2034 (USD Billion)

Table 37: Nordic Nucleic Acid Therapeutics CDMO Market Size and Forecast By Type - 2022-2034 (USD Billion)

Table 38: Nordic Nucleic Acid Therapeutics CDMO Market Size and Forecast By Service - 2022-2034 (USD Billion)

Table 39: Nordic Nucleic Acid Therapeutics CDMO Market Size and Forecast By End Use - 2022-2034 (USD Billion)

Table 40: Benelux Nucleic Acid Therapeutics CDMO Market Size and Forecast By Type - 2022-2034 (USD Billion)

Table 41: Benelux Nucleic Acid Therapeutics CDMO Market Size and Forecast By Service - 2022-2034 (USD Billion)

Table 42: Benelux Nucleic Acid Therapeutics CDMO Market Size and Forecast By End Use - 2022-2034 (USD Billion)

Table 43: Rest of Europe Nucleic Acid Therapeutics CDMO Market Size and Forecast By Type - 2022-2034 (USD Billion)

Table 44: Rest of Europe Nucleic Acid Therapeutics CDMO Market Size and Forecast By Service - 2022-2034 (USD Billion)

Table 45: Rest of Europe Nucleic Acid Therapeutics CDMO Market Size and Forecast By End Use - 2022-2034 (USD Billion)

Table 46: APAC Nucleic Acid Therapeutics CDMO Market Size and Forecast By Country - 2022-2034 (USD Billion)

Table 47: APAC Nucleic Acid Therapeutics CDMO Market Size and Forecast By Type - 2022-2034 (USD Billion)

Table 48: APAC Nucleic Acid Therapeutics CDMO Market Size and Forecast By Service - 2022-2034 (USD Billion)

Table 49: APAC Nucleic Acid Therapeutics CDMO Market Size and Forecast By End Use - 2022-2034 (USD Billion)

Table 50: China Nucleic Acid Therapeutics CDMO Market Size and Forecast By Type - 2022-2034 (USD Billion)

Table 51: China Nucleic Acid Therapeutics CDMO Market Size and Forecast By Service - 2022-2034 (USD Billion)

Table 52: China Nucleic Acid Therapeutics CDMO Market Size and Forecast By End Use - 2022-2034 (USD Billion)

Table 53: Korea Nucleic Acid Therapeutics CDMO Market Size and Forecast By Type - 2022-2034 (USD Billion)

Table 54: Korea Nucleic Acid Therapeutics CDMO Market Size and Forecast By Service - 2022-2034 (USD Billion)

Table 55: Korea Nucleic Acid Therapeutics CDMO Market Size and Forecast By End Use - 2022-2034 (USD Billion)

Table 56: Japan Nucleic Acid Therapeutics CDMO Market Size and Forecast By Type - 2022-2034 (USD Billion)

Table 57: Japan Nucleic Acid Therapeutics CDMO Market Size and Forecast By Service - 2022-2034 (USD Billion)

Table 58: Japan Nucleic Acid Therapeutics CDMO Market Size and Forecast By End Use - 2022-2034 (USD Billion)

Table 59: India Nucleic Acid Therapeutics CDMO Market Size and Forecast By Type - 2022-2034 (USD Billion)

Table 60: India Nucleic Acid Therapeutics CDMO Market Size and Forecast By Service - 2022-2034 (USD Billion)

Table 61: India Nucleic Acid Therapeutics CDMO Market Size and Forecast By End Use - 2022-2034 (USD Billion)

Table 62: Australia Nucleic Acid Therapeutics CDMO Market Size and Forecast By Type - 2022-2034 (USD Billion)

Table 63: Australia Nucleic Acid Therapeutics CDMO Market Size and Forecast By Service - 2022-2034 (USD Billion)

Table 64: Australia Nucleic Acid Therapeutics CDMO Market Size and Forecast By End Use - 2022-2034 (USD Billion)

Table 65: Taiwan Nucleic Acid Therapeutics CDMO Market Size and Forecast By Type - 2022-2034 (USD Billion)

Table 66: Taiwan Nucleic Acid Therapeutics CDMO Market Size and Forecast By Service - 2022-2034 (USD Billion)

Table 67: Taiwan Nucleic Acid Therapeutics CDMO Market Size and Forecast By End Use - 2022-2034 (USD Billion)

Table 68: South East Asia Nucleic Acid Therapeutics CDMO Market Size and Forecast By Type - 2022-2034 (USD Billion)

Table 69: South East Asia Nucleic Acid Therapeutics CDMO Market Size and Forecast By Service - 2022-2034 (USD Billion)

Table 70: South East Asia Nucleic Acid Therapeutics CDMO Market Size and Forecast By End Use - 2022-2034 (USD Billion)

Table 71: Rest of Asia-Pacific Nucleic Acid Therapeutics CDMO Market Size and Forecast By Type - 2022-2034 (USD Billion)

Table 72: Rest of Asia-Pacific Nucleic Acid Therapeutics CDMO Market Size and Forecast By Service - 2022-2034 (USD Billion)

Table 73: Rest of Asia-Pacific Nucleic Acid Therapeutics CDMO Market Size and Forecast By End Use - 2022-2034 (USD Billion)

Table 74: Middle East and Africa Nucleic Acid Therapeutics CDMO Market Size and Forecast By Country - 2022-2034 (USD Billion)

Table 75: Middle East and Africa Nucleic Acid Therapeutics CDMO Market Size and Forecast By Type - 2022-2034 (USD Billion)

Table 76: Middle East and Africa Nucleic Acid Therapeutics CDMO Market Size and Forecast By Service - 2022-2034 (USD Billion)

Table 77: Middle East and Africa Nucleic Acid Therapeutics CDMO Market Size and Forecast By End Use - 2022-2034 (USD Billion)

Table 78: UAE Nucleic Acid Therapeutics CDMO Market Size and Forecast By Type - 2022-2034 (USD Billion)

Table 79: UAE Nucleic Acid Therapeutics CDMO Market Size and Forecast By Service - 2022-2034 (USD Billion)

Table 80: UAE Nucleic Acid Therapeutics CDMO Market Size and Forecast By End Use - 2022-2034 (USD Billion)

Table 81: Turkey Nucleic Acid Therapeutics CDMO Market Size and Forecast By Type - 2022-2034 (USD Billion)

Table 82: Turkey Nucleic Acid Therapeutics CDMO Market Size and Forecast By Service - 2022-2034 (USD Billion)

Table 83: Turkey Nucleic Acid Therapeutics CDMO Market Size and Forecast By End Use - 2022-2034 (USD Billion)

Table 84: Saudi Arabia Nucleic Acid Therapeutics CDMO Market Size and Forecast By Type - 2022-2034 (USD Billion)

Table 85: Saudi Arabia Nucleic Acid Therapeutics CDMO Market Size and Forecast By Service - 2022-2034 (USD Billion)

Table 86: Saudi Arabia Nucleic Acid Therapeutics CDMO Market Size and Forecast By End Use - 2022-2034 (USD Billion)

Table 87: South Africa Nucleic Acid Therapeutics CDMO Market Size and Forecast By Type - 2022-2034 (USD Billion)

Table 88: South Africa Nucleic Acid Therapeutics CDMO Market Size and Forecast By Service - 2022-2034 (USD Billion)

Table 89: South Africa Nucleic Acid Therapeutics CDMO Market Size and Forecast By End Use - 2022-2034 (USD Billion)

Table 90: Egypt Nucleic Acid Therapeutics CDMO Market Size and Forecast By Type - 2022-2034 (USD Billion)

Table 91: Egypt Nucleic Acid Therapeutics CDMO Market Size and Forecast By Service - 2022-2034 (USD Billion)

Table 92: Egypt Nucleic Acid Therapeutics CDMO Market Size and Forecast By End Use - 2022-2034 (USD Billion)

Table 93: Nigeria Nucleic Acid Therapeutics CDMO Market Size and Forecast By Type - 2022-2034 (USD Billion)

Table 94: Nigeria Nucleic Acid Therapeutics CDMO Market Size and Forecast By Service - 2022-2034 (USD Billion)

Table 95: Nigeria Nucleic Acid Therapeutics CDMO Market Size and Forecast By End Use - 2022-2034 (USD Billion)

Table 96: Rest of MEA Nucleic Acid Therapeutics CDMO Market Size and Forecast By Type - 2022-2034 (USD Billion)

Table 97: Rest of MEA Nucleic Acid Therapeutics CDMO Market Size and Forecast By Service - 2022-2034 (USD Billion)

Table 98: Rest of MEA Nucleic Acid Therapeutics CDMO Market Size and Forecast By End Use - 2022-2034 (USD Billion)

Table 99: LATAM Nucleic Acid Therapeutics CDMO Market Size and Forecast By Country - 2022-2034 (USD Billion)

Table 100: LATAM Nucleic Acid Therapeutics CDMO Market Size and Forecast By Type - 2022-2034 (USD Billion)

Table 101: LATAM Nucleic Acid Therapeutics CDMO Market Size and Forecast By Service - 2022-2034 (USD Billion)

Table 102: LATAM Nucleic Acid Therapeutics CDMO Market Size and Forecast By End Use - 2022-2034 (USD Billion)

Table 103: Brazil Nucleic Acid Therapeutics CDMO Market Size and Forecast By Type - 2022-2034 (USD Billion)

Table 104: Brazil Nucleic Acid Therapeutics CDMO Market Size and Forecast By Service - 2022-2034 (USD Billion)

Table 105: Brazil Nucleic Acid Therapeutics CDMO Market Size and Forecast By End Use - 2022-2034 (USD Billion)

Table 106: Mexico Nucleic Acid Therapeutics CDMO Market Size and Forecast By Type - 2022-2034 (USD Billion)

Table 107: Mexico Nucleic Acid Therapeutics CDMO Market Size and Forecast By Service - 2022-2034 (USD Billion)

Table 108: Mexico Nucleic Acid Therapeutics CDMO Market Size and Forecast By End Use - 2022-2034 (USD Billion)

Table 109: Argentina Nucleic Acid Therapeutics CDMO Market Size and Forecast By Type - 2022-2034 (USD Billion)

Table 110: Argentina Nucleic Acid Therapeutics CDMO Market Size and Forecast By Service - 2022-2034 (USD Billion)

Table 111: Argentina Nucleic Acid Therapeutics CDMO Market Size and Forecast By End Use - 2022-2034 (USD Billion)

Table 112: Chile Nucleic Acid Therapeutics CDMO Market Size and Forecast By Type - 2022-2034 (USD Billion)

Table 113: Chile Nucleic Acid Therapeutics CDMO Market Size and Forecast By Service - 2022-2034 (USD Billion)

Table 114: Chile Nucleic Acid Therapeutics CDMO Market Size and Forecast By End Use - 2022-2034 (USD Billion)

Table 115: Colombia Nucleic Acid Therapeutics CDMO Market Size and Forecast By Type - 2022-2034 (USD Billion)

Table 116: Colombia Nucleic Acid Therapeutics CDMO Market Size and Forecast By Service - 2022-2034 (USD Billion)

Table 117: Colombia Nucleic Acid Therapeutics CDMO Market Size and Forecast By End Use - 2022-2034 (USD Billion)

Table 118: Rest of LATAM Nucleic Acid Therapeutics CDMO Market Size and Forecast By Type - 2022-2034 (USD Billion)

Table 119: Rest of LATAM Nucleic Acid Therapeutics CDMO Market Size and Forecast By Service - 2022-2034 (USD Billion)

Table 120: Rest of LATAM Nucleic Acid Therapeutics CDMO Market Size and Forecast By End Use - 2022-2034 (USD Billion)

We are featured on: